1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6211)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13088)
  2. Department of Medicine (13004)
  3. Center for Hematologic Malignancies (10395)
  4. GSK Faculty (4422)
  5. Adult Leukemia (3583)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (775)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (204)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (431)

More Publishers

Results (13088)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Validation of the international harmonization project (IHP) guidelines in early stage Hodgkin lymphoma (HL) treated with adriamycin, vinblastine and gemcitabine (AVG) (CALGB 50203): Early results
    Meeting Abstract

    Kostakoglu, L.; Straus, D. J.; Schoder, H.; LaCasce, A. S.; Bartlett, N. L.; Hall, N.; Johnson, J. L.; Jung, S. H.; Canellos, G. P.; Schwartz, L. H.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Efficacy of extracorporeal photopheresis (ECP) monotherapy in the treatment of cutaneous T cell lymphoma (CTCL)
    Meeting Abstract

    Knobler, R.; Foss, F.; Duvic, M.; Straus, D.; Horwitz, S.; Zain, J.; Kuzel, T.; Querfeld, C.; Campbell, K.; Geskin, L.
    Journal of Investigative Dermatology (2008)

    Fulltext@MSK | Save
  • Il-17 is required for Cd4-mediated GVHD
    Meeting Abstract

    Kappel, L. W.; Goldberg, G. L.; Ivanov, I. I.; Na, I. K.; King, C.; Suh, D.; Smith, O. M.; Ligh, C.; Littman, D. R.; van den Brink, M. R. M.
    Biology of Blood and Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • Previously unknown interactions between AML1 and MLL provide epigenetic regulation of gene expression in normal hematopoiesis and in leukemia
    Meeting Abstract

    Huang, G.; Elf, S.; Yan, X. M.; Wang, L.; Liu, Y.; Sashida, G.; Gural, A.; Menendez, S.; Lee, J.; Yang, Y. Y.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • A phase 1/2A open-label study of pralatrexate and gemcitabine in patients with relapsed or refractory lympboprolifierative malignancies
    Meeting Abstract

    Horwitz, S. M.; Vose, J. M.; Advani, R.; Sankhala, K.; Padmanabhan, S.; Hamlin, P. A.; Chen, A.; Wilroy, S.; Zain, J. M.; Wright, D.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Clofarabine is active in peripheral T-cell lymphomas: Results of the phase I portion of a phase I/II study
    Meeting Abstract

    Horwitz, S.; Mulford, D.; Paul, H.; Weissbrot, H.; Zelenetz, A. D.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Pralatrexate (PDX) is active in cutaneous T-cell lymphoma: Preliminary results of a multi-center dose-finding trial
    Meeting Abstract

    Horwitz, S. M.; Duvic, M.; Kim, Y.; Zain, J. M.; Lechowicz, M. J.; Myskowski, P.; Weissbrot, H.; Wright, D.; Chance, L.; Koutsoukos, T.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Low dose pralatrexate (PDX) is active in cutaneous T-cell lymphoma: Preliminary results of a multi-center dose finding trial
    Meeting Abstract

    Horwitz, S.; Duvic, M.; Kim, Y.; Chance, L.; Myskowski, P.; Talpur, R.; Morales, A.; Saunders, M.; O'connor, O.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Influence of post-second-line chemotherapy PET Imaging and involved field radiotherapy prior to high dose therapy on outcomes of relapsed or refractory diffuse large B cell lymphoma
    Meeting Abstract

    Hoppe, B. S.; Moskowitz, C. H.; Zhang, Z.; Kewalramani, T.; Maragulia, J. C.; Rice, R. D.; Reiner, A. S.; Hamlin, P. A.; Zelenetz, A. D.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2008)

    Fulltext@MSK | Save
  • Early adjuvant treatment after risk-adapted autologous stem cell transplant for systemic light-chain amyloidosis: Increased hospitalizations and impaired immune recovery but improved responses and overall survival
    Meeting Abstract

    Hoffman, J. E.; Hassoun, H.; Landau, H.; Hoover, E.; Cohen, A.; Nimer, S.; Comenzo, R.
    Blood (2008)

    Fulltext@MSK | Save